American Society of Hirudotherapy

Monitoring Breast Reconstruction Flaps Using Near-Infrared Spectroscopy Tissue Oximetry

Research article published in Plastic surgical nursing : official journal of the American Society of Plastic and Reconstructive Surgical Nurses (2024)

Last Updated: June 18, 2026Reviewed by: ASH Editorial Board
Research article — evidence reviewArticle reference
Evidence: Observational studyDrug DevelopmentKumbasar DE et al. · Plastic surgical nursing : official journal of the American Society of Plastic and Reconstructive Surgical Nurses, 2024

Abstract

Free flap reconstruction is a common procedure with success rates greater than 99%. However, vascular complications may occur, resulting in flap failure. For this reason, early detection of vascular compromise is crucial for flap salvage. Vascular complications may be detected early by monitoring tissue oximetry parameter changes using near-infrared spectroscopy (NIRS). This method of noninvasive monitoring can evaluate changes in flap oxygenation levels caused by arterial and venous thrombosis before surgical reexploration. The goal of this study was to assess the validity of using NIRS oximetry for monitoring free flaps. We conducted a prospective cohort observational study of 10 patients undergoing breast reconstruction. We used the INVOS 7100 cerebral oximetry monitoring system (Medtronic, Dublin, Ireland) to provide 24-hr continuous postoperative monitoring of flap perfusion and compared the data with clinical assessment findings. The median patient age was 57 years (range = 41-61 years). Patients underwent immediate breast reconstruction with deep inferior epigastric perforator (DIEP) flap surgery (n = 4), delayed reconstruction with DIEP flap surgery (n = 4), transverse upper gracilis flap surgery (n = 1), and latissimus dorsi flap with lipofilling (n = 1). We successfully monitored all 10 flaps for 24 hr postoperatively. The overall flap survival rate was 100%. Findings of clinical examination, Doppler studies, and surgical outcome were consistent with NIRS monitoring. In conclusion, NIRS tissue oximetry could potentially provide a noninvasive method for effective postoperative monitoring of free flaps.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeJournal ArticleObservational Study
Indexed MeSH termsAdultCohort StudiesFemaleHumansMammaplastyMiddle AgedMonitoring, PhysiologicOximetryProspective StudiesSpectroscopy, Near-InfraredSurgical FlapsVictoria

Summary

Free flap reconstruction is a common procedure with success rates greater than 99%.

Why This Matters for Hirudotherapy

This prospective cohort observational study of 10 patients evaluated the use of near-infrared spectroscopy (NIRS) tissue oximetry for 24-hour continuous postoperative monitoring of free flaps in breast reconstruction, finding 100% flap survival and consistency between NIRS readings, clinical examination, Doppler studies, and surgical outcomes. The abstract notes that NIRS can evaluate changes in flap oxygenation caused by arterial and venous thrombosis before surgical reexploration. The study does not involve leeches, hirudotherapy, or any leech-derived agents. There is no direct relevance to ASH's domain; the study addresses a perfusion monitoring technology in flap surgery without any leech-related content.

Citation

Monitoring Breast Reconstruction Flaps Using Near-Infrared Spectroscopy Tissue Oximetry

Kumbasar DE et al. · Plastic surgical nursing : official journal of the American Society of Plastic and Reconstructive Surgical Nurses, 2024

Added to ASH library: May 27, 2026 · Site last updated: June 18, 2026

This website provides educational information and does not constitute medical advice, diagnosis, or treatment recommendations. Medicinal leech therapy carries clinically meaningful risks and should be performed only by qualified clinicians under institutionally approved protocols. FDA 510(k) clearance for medicinal leeches is limited to specific indications; investigational and off-label discussions are labeled accordingly. For patient-specific guidance, consult a qualified healthcare provider.